The last two weeks, the COVID-19 It re-emerged as a topic after a mutated variant of Omicron appeared in Europe and the United States, called BQ.1 and BQ.1.1, also nicknamed “Hellhound” and which until now is known to have an increased ability to escape the immune response of the human being. Although, yes, for the moment they have not found data that demonstrate a greater incidence or severity in the cases detected.
Name “Hellhound” or “Hound of hell” (hellhound in English) became popular among users of social networks and refers to the dog of the god Hades, god of the dead and the underworld, called “Cancerbero” or “Cerbero”. This dog from Greek mythology was the fierce guardian of the gates of hell, and he watched that the dead did not escape and, at the same time, that the living could not enter the underworld.
According to ECDC estimates, more than 50% of COVID infections will be due to BQ.1 and BQ.1.1 in early/mid December. By early 2023, they could account for more than 80% of cases.
The World Health Organization (WHO) noted that “so far there is no epidemiological evidence that these sublineages have a substantially increased risk compared to other Omicron sublineages”, however, it recommended that these variants continue to be monitored and studied.
“Although there are no data on severity or immunological escape from human studies, BQ.1 is showing a significant growth advantage over other omicron sublineages circulating in many settings, including Europe and the United States, and thus warrants further investigation. close surveillance,” the WHO explained in its October 2022 report.
According to the Centers for Disease Control and Prevention (CDC), the symptoms of the Omicron subvariants, BQ.1 and BQ.1.1, as well as those of other variants, are as follows:
– Fever or chills
– Cough, shortness of breath or difficulty breathing
– Fatigue and/or muscle or body aches.
– New loss of taste or smell
– Congestion or runny nose
– Throat pain
– Nausea, vomiting, or diarrhea